| Age at diagnosis, median (range), years |
61 (55-80) |
58 (56-80) |
62 (55-80) |
| Age at enrollment, median (range), years |
64 (56-87) |
60 (58-82) |
64.5 (56-87) |
| Histological grade, n (%) |
|
|
|
| I |
10 |
0 |
10 (100) |
| II |
31 |
2 (6.5) |
29 (93.5) |
| III |
7 |
3 (42.8) |
4 (57.8) |
| Missing |
1 |
0 |
1 (100) |
| Clinical Stage, n (%) |
|
|
|
| I |
14 |
0 |
14 (100) |
| II |
19 |
1 (5.3) |
18 (94.7) |
| III |
10 |
2 (20) |
8 (80) |
| Missing |
6 |
2 (33.5) |
4 (66.5) |
| Molecular Subtype |
|
|
|
| Luminal A |
11 |
0 |
11 (100) |
| Luminal B |
22 |
3 (13.7) |
19 (86.4) |
| Luminal |
6 |
0 |
6 (100) |
| HER2+ |
5 |
0 |
5 (100) |
| Triple Negative |
5 |
2 (40) |
3 (60) |
| Affected relatives, n (%) |
|
|
|
| First Degree |
34 |
4 (11.8) |
30 (82.2) |
| Second Degree |
9 |
0 |
9 (100) |
| Third Degree |
4 |
1 (25) |
3 (75) |
| Negative |
2 |
0 |
2 (100) |
| Ancestry until second degree, n (%) |
|
|
|
| Brazilian only |
13 |
2 (15.4) |
11 (84.6) |
| European only |
9 |
0 |
9 (100) |
| Asian only |
5 |
1 (20) |
4 (80) |
| Brazilian and European |
14 |
1 (7.2) |
13 (92.8) |
| Brazilian and Indigenous |
1 |
0 |
1 (100) |
| Brazilian and Australian |
1 |
1 (100) |
0 |
| Brazilian and South American |
1 |
0 |
1 (100) |
| Brazilian and European and Australian |
1 |
0 |
1 (100) |
| Indigenous and European |
1 |
0 |
1 (100) |
| European and Unknown |
1 |
0 |
1 (100) |
| Indigenous and Unknown |
1 |
0 |
1 (100) |
| Unknown |
1 |
0 |
1 (100) |
| Region of origin, n (%) |
|
|
|
| Southeast |
33 |
2 (6) |
31 (94) |
| Northeast |
9 |
2 (22.2) |
7 (77.8) |
| South |
3 |
0 |
3 (100) |
| Abroad |
4 |
1 (25) |
3 (75) |
